Related Experiment Videos
Management of central retinal vein occlusion
1Department of Ophthalmology and Visual Sciences, College of Medicine, University of Iowa, Iowa City, Iowa, USA. sohan-hayreh@uiowa.edu
Insights
Differentiating between ischemic and non-ischemic central retinal vein occlusion (CRVO) is crucial for management. Current treatments for CRVO lack proven efficacy, emphasizing the need for further research.
Area of Science:
- Ophthalmology
- Retinal Vascular Diseases
Background:
- Central retinal vein occlusion (CRVO) management requires accurate diagnosis.
- Prognosis, complications, and visual outcomes differ significantly between ischemic and non-ischemic CRVO.
Purpose of the Study:
- To review the essential steps in managing CRVO.
- To evaluate parameters for differentiating CRVO subtypes.
- To discuss current CRVO treatment modalities and controversies.
Main Methods:
- Review of parameters for differentiating ischemic from non-ischemic CRVO.
- Summary of the natural history of CRVO.
- Discussion of advocated treatments, including photocoagulation.
Main Results:
- Accurate differentiation of CRVO types is essential but challenging.
- The 10-disc area of retinal capillary obliteration is an invalid parameter for differentiating CRVO subtypes or predicting neovascularization.
- Ocular neovascularization is a complication exclusive to ischemic CRVO.
- Current treatments for CRVO have limited proven efficacy.
Conclusions:
- Effective management of CRVO hinges on correct subtype differentiation.
- Extensive workups are generally unnecessary for CRVO patients beyond routine evaluations.
- Despite various therapies, no consistently safe and effective treatment for CRVO is currently established.
Abstract:
The management of central retinal vein occlusion (CRVO) is discussed briefly. Since the prognosis, complications, visual outcome and management of nonischemic and ischemic CRVO are very different, the first essential step in the management of CRVO is to determine which type of CRVO one is dealing with. The various parameters which help to differentiate the two types reliably are described briefly. In this connection, the most important thing to remember is that the conventional, very prevalent use of a 10-disc area of retinal capillary obliteration is an invalid parameter to differentiate ischemic from nonischemic CRVO, or to predict ocular neovascularization (NV). Ocular NV is a complication of ischemic CRVO only. Relevant issues about the natural history of CRVO are summarized; the natural history of the disease must not be mistaken for a beneficial effect of treatment. Various advocated modes of treatment of CRVO and their relative merits are discussed, particularly photocoagulation, which is widely advocated. Controversies with regard to various aspects of CRVO management are examined. Finally, it is noted that apart from routine systemic and hematologic evaluations, the vast majority of patients with CRVO do not need an extensive and expensive workup. In conclusion, in spite of enthusiastic claims of success for various therapies, the reality is that we currently have practically no proven safe and effective treatment for CRVO.